Wednesday, August 17, 2022 7:00:00 AM
Recent RPHM News
- Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm • PR Newswire (US) • 07/01/2024 07:13:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/13/2024 01:38:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:14:11 PM
- Reneo Pharmaceuticals and OnKure Announce Proposed Merger • GlobeNewswire Inc. • 05/13/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:03:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:00:15 PM
- Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 11:35:00 AM
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update • GlobeNewswire Inc. • 03/28/2024 11:35:00 AM
- Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:00:15 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:01:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:26:00 PM
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 12/14/2023 02:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/22/2023 05:15:05 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 10:08:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/13/2023 09:58:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:00:11 PM
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/13/2023 12:35:00 PM
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/02/2023 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:47:24 PM
- Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings • GlobeNewswire Inc. • 10/25/2023 11:50:00 AM
- Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 10/09/2023 11:50:00 AM
- Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit • GlobeNewswire Inc. • 10/06/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:04:03 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM